Corporate Social Responsibility

Corporate social responsibility is fundamental to the Viatris mission. We work to advance responsible and sustainable operations and leverage our collective expertise to empower people to live healthier at every stage of life, recognizing that our actions affect the stakeholders and communities we serve.

Read our 2021 Sustainability Report

Read our 2021 Sustainability Report

Viatris 2021 Sustainability Fact Sheet

A letter from our CEO Michael Goettler

Our Commitment to Sustainability

We believe that everyone deserves to live a healthy life. With only about half of the global population able to receive essential health services – a figure further exacerbated by the COVID-19 pandemic – there is much to be done to ensure sustainable access to medicines worldwide. Our Sustainability Report aims to continue establishing Viatris as a new kind of healthcare company, including furthering our global commitments.

In 2020, Viatris became a signatory to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, the environment and anti-corruption.

“As a signatory to the UN Global Compact, we are committed to its 10 principles and believe companies can be a force for good. It is essential that we work to be enablers of potential solutions to some of society’s most pressing challenges.”

Michael Goettler, CEO, Viatris

Featured CSR News

Supporting Viatris Colleagues: An Account of the Early Days of the Crisis in Ukraine

In February 2022, as the gravity of the situation in Ukraine deepened, a dedicated Viatris team worked around the clock to bring their colleagues to safety. Though the situation continues to evolve, those few weeks were life changing not only for the people caught in the crossfire, but also for those who worked so hard to help them.

Other CSR Highlights

Supporting the Mental Well-being of Children

Viatris partnered with Sesame Workshop, the nonprofit behind Sesame Street, to support the social and emotional needs of families across generations as they collectively continue to adapt to the impacts of the COVID-19 pandemic.

Learn more about our commitment to sustainability

Access and Global Health

We believe strongly in doing our part to build a better future by helping tackle some of the world’s most complex health problems.

Environmental Stewardship

A healthy planet is vital to accomplishing our mission of empowering people worldwide to live healthier at every stage of life.

Engaging Employees

Our mission motivates us to bring our best every day as we create a performance-driven, highly engaging and inclusive organization.

Responding to the Challenges of COVID-19

The health and safety of our colleagues and their families and maintaining business operations for the patients who rely on us were our highest priorities in 2021 as the COVID-19 pandemic persisted, spreading through new variants around the world.

Supporting Communities

We seek to foster healthy communities around the world by supporting education, health and disease awareness efforts that, in particular, promote empowering patients and creating access to care. We work via in-kind and monetary donations, volunteering our time and talents and engaging with partners to find solutions.

Ensuring Patient Safety and Quality

Protecting patient health by ensuring the quality and safety of our products is at the heart of how we operate across our network. Every step of our development, manufacturing and monitoring processes - from product development to sourcing of raw materials to producing finished dosage forms and delivering that product - is grounded in this commitment.

Enhancing Supplier Relationships

At Viatris, we rely on suppliers and business partners to deliver affordable and accessible products to our customers and ultimately to patients. Building strong and long-term relationships helps to reduce risk, enhances resilience and ensures a high quality and reliable supply.

Acting with Integrity

As we explore new opportunities for Viatris, we are committed to conducting all aspects of our business with integrity and upholding responsible business practices in our own operations as well as in external engagements.

We have clear procedures to mitigate risks and support employees in their everyday work life, including but not limited to interaction with healthcare professionals, marketing and communication, anti-corruption and fair competition, partnerships and supplier relations.

Building Partnerships

As a trusted Partner of Choice^™ for healthcare systems, professionals, and organizations, we are dedicated to expanding access to medicine for patients throughout our communities and around the world. We are committed to providing the tools, guidance, healthcare education and outreach necessary to connect patients to trusted, high-quality medications.

Partners for Progress

Business partnerships, memberships and philanthropic collaborations help us reach patients and communities worldwide.

Additional Information

Policies

FAQs

How is Viatris addressing the global challenge of climate change?

Climate change is impacting public health, and as a healthcare company with a global presence, we must do our part to address climate change head-on. (See our Global Climate Change Policy). We have committed to set near-term companywide emission reduction targets in line with the latest climate science, in accord with The Science Based Target Initiative (SBTi). We have submitted our reductions to SBTi for validation, and we expect approval by the end of 2022.

• Our targets are to reduce Scope 1 and 2 emissions by 42% by 2030 from a 2020 baseline and to reduce Scope 3 emissions by 25% by 2030 from a 2020 baseline.

To achieve our Scope 3 target, we plan to further intensify our supplier engagement. For our suppliers, we plan to develop and deploy a program to help us collect additional supplier data. Ultimately, we want to support our suppliers in setting their own science-based targets.

We have also worked with our suppliers to reduce our GHG emissions from freight transportation. We have increased the number of products shipped via ocean to more than 60%.

Operations sites set various short-term strategies to help progress the company’s overall commitments and goals. These include increasing the purchase of renewable energy, utilizing alternative fuel sources, reducing fugitive emissions, and phasing out ozone-depleting substances.

We are implementing energy-efficiency and emissions-reduction projects and are tracking GHG emissions monthly, evaluating GHG reductions annually and re-evaluating short- and long-term emission reduction strategies as needed to achieve our targets.

For examples across the Viatris network, please see our 2021 Sustainability report.

In addition to the above-noted climate targets, we have also launched initial water and waste goals. Please learn more in our 2021 Sustainability report.

What is Viatris doing to address antimicrobial resistance (AMR)?

As a global pharmaceutical company whose mission it is to empower people worldwide to live healthier at every stage of life by providing access to high-quality trusted medicines, Viatris is committed to working with stakeholders across the industry to combat antimicrobial resistance (AMR), which occurs when pathogens, such as bacteria or viruses, evolve to withstand the effects of medicines like antibiotics or antiretrovirals. AMR is a significant threat to global health and economic development and is a leading cause of death globally. Recent research shows that in 2019, more than 1.2 million people are estimated to have died directly from antibiotic-resistant bacterial infections, and nearly 5 million deaths were associated with bacterial AMR.¹ By 2050, it is estimated that AMR will cause more deaths than cancer.

Many factors contribute to AMR, including poor infection control and the over-prescribing and inappropriate use of antibiotics. Fighting AMR requires a multipronged approach and the collaboration of many stakeholders.

As a founding member of the AMR Industry Alliance (AMR IA), we are committed to partnering across industry to collectively advance initiatives addressing AMR. These efforts have led to progress in advancing science-based approaches to help manage the impact of antimicrobial manufacturing, develop initiatives to enhance antibiotic stewardship and improve sustainable access to appropriate antibiotics. Access to high-quality antimicrobials and timely treatment is key in mitigating the rise of AMR. Viatris is a leading supplier of antimicrobials, including older antibiotics that can be valuable in treating some resistant bacteria

We have adopted the AMR Industry Alliance Common Antibiotic Manufacturing Framework for our own operations and external supply chain

We recognize the importance of transparency and exchange of good practices as part of striving for collective progress to address AMR. In that spirit, we report on our systematic efforts and progress in our annual sustainability report. We also participate in the AMR Industry Alliance Progress Report and the Access to Medicine Foundation’s AMR Benchmark. In the 2022 AMR Benchmark, Viatris has been recognized as one of the top three generics manufacturers for championing appropriate access, stewardship and responsible manufacturing, including our efforts to make treatment for drug-resistant tuberculosis available in more countries.

To learn more about Viatris’ work in establishing sustainable access to medicine, supporting more resilient healthcare systems, and environmental stewardship – please see our 2021 Sustainability Report.

¹ Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis

Localized information for

Localized information for

Leaving this page

Corporate Social Responsibility

Read our 2021 Sustainability Report